Tolerance and Palatability of 10-day Supplementation With Hemp Oil, Calamari Oil, and Broccoli Extract in Healthy Adults
1 other identifier
interventional
14
1 country
1
Brief Summary
Tolerance and palatability of short-term supplementation with a whole-food dietary formulation based on hemp oil, calamari oil, and broccoli was evaluated in healthy adults. This was a 10-day open-label, prospective, controlled trial (n=14) in which participants acted as their own controls to receive daily intervention standardized to contain 15 mg phytocannabinoids, 230 mg omega-3 fatty acids, and 5 mg glucoraphanin. The primary objective was to evaluate gastrointestinal tolerability and acceptability. The study demonstrated that daily ingestion of the investigational product was well tolerated with no or minor adverse events, and a good palatability. The secondary objectives were to access parameters of blood biochemistry, liver enzymes, biomarkers of immune and oxi-dative health, as well as phytocannabinoid profiles in urine.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 26, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 26, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 26, 2019
CompletedFirst Submitted
Initial submission to the registry
September 25, 2023
CompletedFirst Posted
Study publicly available on registry
October 13, 2023
CompletedOctober 13, 2023
October 1, 2023
1 month
September 25, 2023
October 9, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Tolerance
gastrointestinal and general health measured by daily questionnaire, this is a numbered scale from 1-9 from the Global Quality of Life scale
10 days
palatability
palatability of Standard Process Hemp Oil Complex by questionnaire scale.
10 days
Secondary Outcomes (3)
Oxidative Stress Biomarkers
1 month
Liver Enzymes
1 month
Medical Symptom Questionnaire (MSQ)
10 days
Study Arms (1)
Supplementation
EXPERIMENTALParticipants were enrolled at baseline where all outcome measures were collected. Once baseline visit was complete, participants started with the supplementation of Hemp Oil Complex by Standard Process. After 10 days, outcome measures were collected.
Interventions
10 days of supplementation to determine the tolerance and palatability of Standard Process Hemp Oil Complex.
Eligibility Criteria
You may qualify if:
- Subject is between 18 and 75 years old
- Subject is a male or a non-pregnant, non-lactating female, at least 6 weeks postpartum prior to screening visit, and is not actively planning a pregnancy
- Subject has at least two week wash out period between completion of a previous research study that required ingestion of any study food or drug, and their start in the current study
- No allergy to any study products
- Willingness to comply with study protocol for 10 days
You may not qualify if:
- Subjects who are experiencing any adverse events due to any nutraceutical, OTC, pharmaceutical, or investigational products
- Subjects may not receive any other investigational products not part of normal clinical care
- Lipid lowering drugs or the use of anticoagulant medications in the preceding 4 weeks and for duration of trial
- Subjects with untreated endocrine, neurological, or infectious disease
- Subjects with a current diagnosis or personal history of: significant liver or kidney disease, autoimmune disorders, deep vein thrombosis, history of cancer
- Serious medical illness including a history of attempted suicide
- Use of ethanol within 24 hours of the evaluation visits (baseline, and end of the study visit
- Do not comply with the study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Standard Process Nutrition Innovation Center
Kannapolis, North Carolina, 28081, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 25, 2023
First Posted
October 13, 2023
Study Start
April 26, 2019
Primary Completion
May 26, 2019
Study Completion
May 26, 2019
Last Updated
October 13, 2023
Record last verified: 2023-10